In June 2020, the Company recorded a decrease in sales of 5% YoY.

Sopharma published an announcement on the Sofia Stock Exchange stating that for June 2020 the Company recorded a decrease in sales of 5%  YoY, including a 78% decrease in domestic sales and 59% increase in export sales.

In H1 of 2020 the revenues from sales of production increased by 1% YoY, including a 19% decrease of sales for the domestic market and 13% increase in export sales.